Crossmark

Dextrose prolotherapy versus low level laser therapy in the treatment of patients with obstructive sleep apnea syndrome; a randomized controlled trial

Crossref DOI link: https://doi.org/10.1007/s11325-025-03428-7

Published Online: 2025-08-12

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Attia, Amira A. M. M. https://orcid.org/0000-0002-9856-1572
Haggag, Mai A.

Ahmed, Wael Said

El-Saed, Aiman

Saleh, Mennatalla A. M.

Saleh, Abdelbaset M.
License Information

Text and Data Mining valid from 2025-08-12

Version of Record valid from 2025-08-12
More Information

Article History

Received: 31 May 2025

Revised: 12 July 2025

Accepted: 21 July 2025

First Online: 12 August 2025

Declarations

:

: The study protocol was approved by the institutional review board of the Faculty of Medicine, Mansoura University (NO. R.23.03.2095). The Helsinki Declaration and the guidelines set by the institutional ethics committee were adhered to in all aspects of this study’s activities. Participants in the study provided written informed consent. The study was listed on with registration number (NCT06427161) on 23/05/2024.

: Not applicable.

: Authors declare no competing interests.

Document is current

Any future updates will be listed below